South Korea · Biotechnology
Pharmaceuticals
Biotechnology
Healthcare
HEM Pharma is dedicated to human microbiome research and technology, providing innovative services and products to improve health through personalized analysis and biotechnology. Specializing in microbiome analysis, multi-omics, and metabolomics, HEM Pharma offers services such as personalized analysis, health functional foods, and contract development and manufacturing organization (CDMO). The company focuses on advancing the field of microbiome research and developing new health solutions.
2017
Founded
Biotechnology
Industry
South Korea
Location
313,291,721
Ranking
0 employees
Size

Get full access to view complete information

© Pubrio 2026